In this report we define the activated pathogenic and protective molecular pathways in each major cell type of the glomerulus in the bigenic Cd2ap+/-, Fyn-/- mouse model of FSGS, thereby providing a global view the disease process that might aid in the identification of novel therapeutic targets. This evidence concerns the gene CD2AP and focal segmental glomerulosclerosis.